SEC Form 3 · accession 0001733614-18-000004
UTAH MEDICAL PRODUCTS INC · UTMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Koopman
Officer — Principal Financial Officer
Period of report
Apr 2, 2018
Accepted (ET)
Apr 3, 2018 · 6:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000706698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 907 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option - Right to Buy | $49.18 | holding | — | — | — | Apr 1, 2018 | May 8, 2024 | Common Stock | 62 | — | D |
| Employee Stock Option - Right to BuyF1 | $58.50 | holding | — | — | — | Apr 1, 2018 | Nov 8, 2026 | Common Stock | 687 | — | D |
Explanation of responses
- F162 shares vested 1 April 2018; an additional 62 shares will vest on 1 July 2018 and the first calendar day of each quarter thereafter until fully vested on 1 October 2020.
Remarks
See attached "FOOTNOTES" page.